Postdoctoral and Ph.D. positions in the epigenetics of aging and sex-biased disease

The Andergassen lab at TUM is recruiting a Postdoctoral and Ph.D. candidate to study how epigenetic changes during aging contribute to sex-biased disease. The project combines allele-specific epigenomics, bulk and single-cell sequencing, viral vectors, and CRISPR-based in vivo editing. Candidates will work in a state-of-the-art, international research environment at the Institute of Pharmacology and Toxicology.